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Br Heart J 1991;66: CASE REPORTS Successful stenting of a life threatening pulmonary Aarterial stenosis David Mulcahy, Ulrich Sigwart, Jane Somerville Abstract A 35 year old woman with multiple pulmonary arterial stenoses and occlusions was admitted with increasingly severe breathlessness. Balloon angioplasty of a life threatening stenosis in a remaining pulmonary artery branch was attempted on two occasions but without success. When a self-expanding stainless steel stent was inserted at the site of stenosis after a further angioplasty acute localised pulmonary oedema developed as blood flow distal to the lesion increased considerably. This was followed by a slow and dramatic improvement in the patient's condition. She no longer required an urgent transplant and resumed an active life.
Little is known about the long term natural history and late complications of multiple pulmonary arterial stenoses; progressive occlusion of such stenoses, however, causes increasing hypoxia and breathlessness. Lately, balloon angioplasty has been used to dilate stenosed pulmonary arterial branches,' and in animals stents have been used to prevent restenosis in such lesions.2 We report a patient with multiple pulmonary arterial stenoses and occlusions who underwent stent insertion at the site of a critical stenosis in a remaining pulmonary arterial branch after two failed balloon angioplasties. fig 1) . The main pulmonary artery was aneurysmal. The right lung filled by acquired multiple collateral blood vessels from the bronchial arteries, the left circumflex artery, and the right internal mammary artery. The left lung was also supplied by abnormal collaterals from the left internal mammary artery. All the collaterals were small. In view of the importance of the persisting pulmonary arterial supply to the left lower lobe we planned to perform an elective balloon dilatation of the left lower lobe pulmonary arterial stenosis. The patient deteriorated, however, and was re-admitted as an emergency with severe breathlessness, dizziness, and chest pain, which we believed might have been caused by "silting up" of one or more remaining pulmonary arterial branches. An infusion of streptokinase was started and she was referred for urgent heart-lung transplantation. When the chest pain became worse the streptokinase infusion was replaced with a heparin infusion, and the patient gradually stabilised, with variable oxygen saturations from 60% to 85%. Because she showed slight clinical improvement, we considered that it was worthwhile to attempt angioplasty of the lesion. She underwent balloon dilatation (6 mm and 8 mm balloons) of the left lower lobe pulmonary arterial stenosis on two occasions over the next two weeks; however, there was little change in the transstenotic gradient and little overall improvement in clinical state.The stenotic area was noted to be "rubbery" in its response to stretch. The patient then underwent a third procedure with a 10 mm balloon dilatation of the lesion followed by insertion of a modified self-expanding 12 mm stainless steel wall stent device, and re-inflation of a 10 mm balloon within the stent to smooth it out (fig 2) arteries has been reported to be difficult and often ineffective.34 Because of the complexity of the surgical approach, balloon angioplasty has become popular as a relatively non-invasive method of relieving obstruction to flow within the pulmonary circulation. This method has particular applications in the management of intraparenchymal pulmonary artery stenoses, which may be inaccessible to surgery. Balloon angioplasty has been shown to relieve pulmonary artery stenoses by tearing the vascular intima and media, allowing remodelling and healing at a larger diameter.5
Rothman and colleagues have recently published the results of 218 balloon angioplasty procedures in 135 patients with branch pulmonary artery stenoses.1 They reported a success rate of 60%, a mortality rate of 1%, and aneurysm formation in 3%. Our patient is at the upper end of the series age, and it has been suggested that procedural success diminishes with the age of the patient,6 however, Rothman et al found no such relation.' He did find a positive correlation between success and balloon to artery size ratio. The first two attempts at dilatation in our patient probably failed because the balloon was too small, however, on the third occasion the balloon was large enough but it still did not produce lasting dilatation or improvement in pressure dynamics. Rothman et al reported that according to diameter criteria 25 of 57 procedures in those with follow up angiograms were not initially successful, suggesting a significant incidence where stenoses were not adequately dilated or where there was immediate recoil of such lesions. This was true of our patient, in whom, despite maximal inflation of the balloon without waisting, the stenosis rapidly returned to its pre-dilatation diameter.
Though coronary angioplasty is widely used in patients with coronary artery stenoses, restenosis rates remain high (up to 35%).7 8 Because of this many investigators have attempted to design "mechanical barriers" or stents to insert at the site of lesions to prevent restenosis.9"0 In view of the precarious clinical condition of our patient, and the apparent lack of success with conventional balloon dilatation, a modified stainless steel self-expanding mesh stent was inserted in the branch pulmonary artery after dilatation of the lesion. Further dilatations from within the expanded prosthesis were used to smooth out the stent. The beneficial effects were immediately obvious with a striking increase in distal pressures and reduction in main pulmonary artery pressures. of stents in the management of branch pulmonary artery stenoses becomes more widespread, this complication is likely to become more common. Such procedures should ideally be covered by prophylactic oxygen and intravenous diuretics. It is reassuring to know that standard management of pulmonary oedema leads to gradual resolution of the problem and that the distal pulmonary artery vasculature can rapidly accommodate higher flow and pressure even when hypoperfusion has developed gradually over several decades.
O'Loughlin and colleagues studied the practicality of stent insertion in pulmonary arteries in dogs, and noted that early stent migration occurred but was overcome by the use of larger balloons.2 They noted that side branches crossed by the stents remained patent. Pathological evaluation showed that struts that were in apposition to the vessel wall had a smooth neoendothelial covering. No thromboses or distal thromboemboli were found. As with coronary stents in humans, however, adequate anticoagulation is mandatory at the time of and after stent insertion, and although neoendothelialisation seems to occur in a matter of weeks, most workers would recommend anticoagulation for 3-6 months in view of the thrombotic tendency resulting from stent insertion. In view of the raised pulmonary artery pressure, anticoagulation for life might be the more sensible approach in those with intrapulmonary stents.
Although we cannot be certain of the long term outcome in our patient, the short term palliation of symptoms was strikingly successful. Pulmonary artery stenting seems to be both feasible and effective. With technical advances and measures to counter the complications of thrombosis and "flooding", the stent may increasingly be used in patients with pulmonary artery stenosis.
